5-Gene Risk Score Model Effectively Predicts Prognosis in Multiple Myeloma
Researchers sought to develop and validate a risk score model to predict prognosis for patients with multiple myeloma.
Multiple Myeloma
Patient Perspective on Their Prognosis Affects QOL, Psychological Distress in MM
This study investigated the effects of patients’ perceptions of their disease status and prognosis on quality of life and psychological distress.
Model Serves as Tool to Identify Subgroups of Newly Diagnosed Multiple Myeloma
A new model identifies subgroups of patients with newly diagnosed multiple myeloma based on genomic and transcriptional data and patient outcomes.
Treatment Duration and Interval of Bortezomib, Lenalidomide for MM Predictive of Skin Rash
A retrospective review sought to better understand the relationship between bortezomib and lenalidomide therapy and treatment-induced skin rash in multiple myeloma.
Qualitative Study Sheds Light on Patient Trust in Shared Decision Making in MM Treatment
Researchers conducted semi-structured interviews with patients with multiple myeloma to determine what factors influence their ability to participate in shared decision making with their clinicians.
STEPS Program After HCT for Multiple Myeloma Is Useful Measure of Patient Status
The physical activity intervention was a feasible and accepted program for patients with MM after hematopoietic cell transplantation, and provided useful information regarding patient recovery.
Utilization Patterns Explain Nonadherence to Treatment for Multiple Myeloma, CML, Some Metastatic Cancers
A retrospective study of Medicare data showed a potential factor in nonadherence to oral cancer treatment regimens.
Vertebroplasty, Balloon Kyphoplasty Are Viable Options for PVF in Multiple Myeloma
A review of data in the literature sought to determine whether these procedures have a role in managing vertebral metastasis and subsequent pathological vertebral fractures in patients with MM.
Prognostic Importance of Extramedullary Lesions in Multiple Myeloma
Researchers sought to determine whether extramedullary lesions would be an indicator of prognosis in patients with multiple myeloma treated in the first line with bortezomib.
A Case of Multiple Myeloma Presenting With Ophthalmic Changes
A case report describes an atypical presentation of multiple myeloma marked by immunogammopathy maculopathy and hyperviscosity syndrome-related retinopathy.
- Loading...
Loading...
Next post in news
Loading... 
Loading...